Ossotide Sodium Chloride Injection is a pharmaceutical product designed to address a range of musculoskeletal conditions, including proliferative bone and joint diseases, rheumatism, and rheumatoid arthritis. This article provides an in-depth analysis of its features, benefits, technical specifications, applications, and the background of its manufacturer, Shijiazhuang Kunxiangda Technology Co., Ltd.
Product Features and Benefits
Ossotide Sodium Chloride Injection is formulated as a clear, colorless to slightly yellow liquid, containing a combination of a peptide substance and sodium chloride. The primary active ingredient, the peptide substance, is engineered to regulate bone metabolism, stimulate osteoblast proliferation, and promote new bone formation. This dual-action mechanism not only aids in fracture healing but also helps in managing conditions like osteoporosis by increasing bone calcium deposition and regulating calcium and phosphorus metabolism.
The product also exhibits anti-inflammatory and analgesic properties, making it a valuable treatment option for patients suffering from chronic inflammatory conditions such as rheumatoid arthritis. Its intravenous administration ensures rapid systemic absorption, allowing for efficient therapeutic effects. The sodium chloride component serves as a physiological solvent, maintaining isotonicity and ensuring patient comfort during infusion.
One of the key advantages of Ossotide Sodium Chloride Injection is its targeted approach to musculoskeletal health. Unlike traditional treatments that may only address symptoms, this product directly intervenes in the biological processes underlying bone and joint degeneration. This makes it a preferred choice for patients requiring long-term management of chronic conditions.
Technical Specifications
| Parameter | Details |
|---|---|
| Volume | 100ml |
| Active Ingredient | Ossotide (0.1g) |
| Sodium Chloride Content | 0.87g |
| Formulation | Colorless or slightly yellow clear liquid |
| Packaging | Glass infusion bottles |
| Storage Conditions | Sealed, in a cool and shady place |
| Shelf Life | 2 years |
Usage and Dosage Guidelines
The recommended dosage for Ossotide Sodium Chloride Injection is an intravenous infusion of 50ml to 100ml once daily, depending on the patient's condition. A typical treatment course lasts 15 to 30 days, but the duration may be adjusted based on medical advice. It is critical to follow the prescribed regimen to ensure optimal therapeutic outcomes.
Before administration, healthcare providers must inspect the solution for clarity. If the product appears turbid or discolored, it should be discarded immediately. Patients with a history of allergies should use the product cautiously, and those with severe renal insufficiency should avoid it altogether due to potential adverse effects.
Adverse Reactions and Precautions
While Ossotide Sodium Chloride Injection is generally well-tolerated, it may cause occasional adverse reactions, including fever, rash, and a temporary decrease in blood pressure. These side effects are typically mild and resolve on their own. However, patients experiencing severe allergic reactions should seek immediate medical attention.
The product is contraindicated for pregnant women, as its safety during pregnancy has not been established. Additionally, it should not be administered concurrently with amino acid drugs or alkaline medications, as these combinations may alter the drug's efficacy or increase the risk of complications.
Applications in Medical Practice
Ossotide Sodium Chloride Injection is widely used in the treatment of various musculoskeletal disorders. Its ability to promote fracture healing makes it a critical component of post-operative care for patients recovering from bone injuries. For individuals with rheumatoid arthritis, the product's anti-inflammatory properties help reduce joint pain and stiffness, improving overall quality of life.
In the context of osteoporosis management, Ossotide Sodium Chloride Injection offers a dual benefit by both preventing bone loss and stimulating new bone formation. This makes it particularly useful for elderly patients or those with a high risk of fractures. The product's role in regulating calcium and phosphorus metabolism further enhances its therapeutic value in maintaining bone density.
Company Background: Shijiazhuang Kunxiangda Technology Co., Ltd.
Shijiazhuang Kunxiangda Technology Co., Ltd., the manufacturer of Ossotide Sodium Chloride Injection, is a reputable company based in China. The company specializes in the development and production of pharmaceutical products tailored to address musculoskeletal health. With a commitment to innovation and quality, Shijiazhuang Kunxiangda has established itself as a trusted name in the industry.
The company's dedication to research and development ensures that its products meet the highest standards of efficacy and safety. By leveraging advanced biotechnology and rigorous quality control processes, Shijiazhuang Kunxiangda continues to contribute to the advancement of medical treatments for bone and joint diseases.
References and Authoritative Sources
The development and application of pharmaceutical products like Ossotide Sodium Chloride Injection are supported by extensive research and adherence to international standards. The National Institute of Standards and Technology (NIST) plays a pivotal role in establishing benchmarks for medical devices and pharmaceuticals, ensuring their reliability and effectiveness. As highlighted in NIST's publications, the integration of precise measurements and standardized protocols is essential for the advancement of healthcare technologies (NIST Official Website).
For further information on Ossotide Sodium Chloride Injection, please visit the product page at Ossotide Sodium Chloride Injection Product Page.
Conclusion
Ossotide Sodium Chloride Injection represents a significant advancement in the treatment of musculoskeletal conditions. Its unique formulation, combining a peptide substance with sodium chloride, addresses the root causes of bone and joint diseases while offering targeted therapeutic benefits. With its clear dosage guidelines, minimal adverse effects, and robust manufacturer support, this product is a valuable asset in modern medical practice.
As the healthcare industry continues to evolve, the importance of evidence-based treatments like Ossotide Sodium Chloride Injection cannot be overstated. By adhering to rigorous standards and leveraging innovations in pharmaceutical science, manufacturers like Shijiazhuang Kunxiangda Technology Co., Ltd. ensure that patients receive safe and effective care. For more details, explore the product page and stay informed about the latest developments in musculoskeletal health.
References: